株式会社マツキヨココカラ&カンパニー
Every trade that managers of MatsukiyoCocokara & Co disclose to EDINET (Japan FSA) is tracked on this page. The company sits in the Health Care sector. From 18 October 2025 to 18 October 2026, the disclosure feed for MatsukiyoCocokara & Co logged 2 filings by 1 insider.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
For context, the typical company on the same exchange (median of 3,419 companies) published 3 filings over the same period, against 2 filings here.
Over the last twelve months, not one insider purchase of MatsukiyoCocokara & Co stock was filed.
In the same sector, recent insider purchases at MAIA Biotechnology, Inc. and Cooper Companies, Inc. also feature in our signals. This summary is built from EDINET (Japan FSA) disclosures alone and does not predict where the share price will go.
Transparent value + quality ranking, distinct from the insider signal.
FY ended March 2026 · cache
5 of 5 declarations
Matsukiyo Cocokara & Company is a Japanese company specializing in the health and pharmaceutical sector. It primarily operates in the XTKS market.